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Methods
Reagents
Human plasma C5a and C5adesArg were from Comp Tech. PE-Cy7-anti-human C5aR1 (S5/1) and PE-anti-human C5aR2 (1D9-M12) were from BioLegend. Phospho-specific antibodies, Total IκBα (25/IκBα/MAD-3), p38 MAPK (pT183/pY182) (36/p38), p44/42 ERK1/2 (pT202/pY204) (20A) and Akt (M89-61), were from BD Biosciences.
Competent activation in human blood
Fresh human blood (80 uL) was added to each well of a 96-well polypropylene plate. For induction of C5a, serially diluted heat-killed P. aeruginosa in PBS (20 µL) was added to each CO 2 , heat-killed P. aeruginosa (10 µL) was added to each well at final concentration at 2x10 7 cfu/mL. Plasma was collected after 20 h incubation at 37 o C with 5% CO 2 ; cytokines and chemokines were determined using multiplex kit (Meso Scale Discovery).
Activation of signaling pathways
3 Human monocytes were plated 3-5x10 5 per well in 80 µL X-VIVO™ 15 serum-free medium in a U-bottom 96 well tissue culture plate and sit for 2 h at 37°C with 5% CO 2 . LPS or C5a (final concentration at 100 ng/mL) was added to each well and incubated for ( Table 1 Cell type PD-L1 C5aR1 C5aR2
